Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
293 questions in 51 reviews · ENT
current versionsNo studies 293 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Local anaesthetic injection vs no treatment/placebo Pain intensity at 24 hours postoperatively ‐ not reported · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Sphenopalatine ganglion block vs no treatment/placebo Adverse effect (postoperative vomiting) ‐ not reported · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Sphenopalatine ganglion block vs no treatment/placebo Adverse effect (postoperative bleeding) ‐ not reported · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Local anaesthetic injection vs no treatment/placebo Pain intensity at 48 hours postoperatively ‐ not reported · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Local anaesthetic injection vs no treatment/placebo Requirement for additional analgesia · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Local anaesthetic injection vs no treatment/placebo Duration of hospitalisation ‐ not reported · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Local anaesthetic injection vs no treatment/placebo Adverse effect (postoperative bleeding) ‐ not reported · septal surgery Perioperative local anaesthesia for reducing pain following septal surgery (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of patients with control of vertigo or decrease in vertigo attacks · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of patients with adverse effects (e.g. hyponatraemia, mood disturbance and headaches) · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of patients with loss or gain of hearing/reduction in progression of hearing loss · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of patients with a reduction in the severity of tinnitus · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Proportion of patients with a reduction in the perception of aural fullness · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Overall changes in well‐being and quality of life · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Any other adverse effects · adults with Ménière's disease or syndrome Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome (2018) · Cochrane | no estimate extracted | NR | No studies |
Systemic antifungal vs placebo/no treatment Adverse effects ‐ allergic reactions · chronic rhinosinusitis Topical and systemic antifungal therapy for chronic rhinosinusitis (2018) · Cochrane | no estimate extracted | NR | No studies |
Systemic antifungal vs placebo/no treatment Generic health‐related quality of life · chronic rhinosinusitis Topical and systemic antifungal therapy for chronic rhinosinusitis (2018) · Cochrane | no estimate extracted | NR | No studies |
Saline irrigation plus pharmacological treatment vs pharmacological treatment alone Individual symptom scores ‐ not measured · allergic rhinitis Saline irrigation for allergic rhinitis (2018) · Cochrane | no estimate extracted | NR | No studies |
Saline vs no saline treatment Individual symptom scores ‐ not measured · allergic rhinitis Saline irrigation for allergic rhinitis (2018) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy Overall survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy Disease‐free survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy Swallowing ability · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose adjuvant radiotherapy vs standard‐dose adjuvant radiotherapy Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy Overall survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy Disease‐free survival · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy Swallowing ability · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Standard‐dose adjuvant radiotherapy alone vs adjuvant chemoradiotherapy Voice (Voice Handicap Index) · patients with HPV‐positive oropharyngeal carcinoma who have received minimally invasive transoral surgery De‐intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral… (2018) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo (with concurrent medication) Tinnitus symptom severity · patients with subjective idiopathic tinnitus Betahistine for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo (with concurrent medication) Depressive symptoms · patients with subjective idiopathic tinnitus Betahistine for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo (with concurrent medication) Symptoms of generalised anxiety · patients with subjective idiopathic tinnitus Betahistine for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo Depressive symptoms · patients with subjective idiopathic tinnitus Betahistine for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Betahistine vs placebo Symptoms of generalised anxiety · patients with subjective idiopathic tinnitus Betahistine for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Combination hearing aid vs hearing aid Significant adverse effect: increase in self‐reported tinnitus loudness · adults with subjective idiopathic tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Combination hearing aid vs hearing aid Depressive symptoms or depression as measured by a validated instrument · adults with subjective idiopathic tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Combination hearing aid vs hearing aid Anxiety symptoms or generalised anxiety as measured by a validated instrument · adults with subjective idiopathic tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Combination hearing aid vs hearing aid Health‐related quality of life as measured by a validated instrument · adults with subjective idiopathic tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Combination hearing aid vs hearing aid Adverse effects associated with wearing the device (such as pain, discomfort, tenderness or skin irritation, or ear infections) · adults with subjective idiopathic tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Hearing aid vs sound generator Significant adverse effect: increase in self‐reported tinnitus loudness · adults with tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Hearing aid vs sound generator Depressive symptoms or depression as measured by a validated instrument · adults with tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Hearing aid vs sound generator Anxiety symptoms or generalised anxiety as measured by a validated instrument · adults with tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Hearing aid vs sound generator Health‐related quality of life as measured by a validated instrument · adults with tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Hearing aid vs sound generator Adverse effects associated with wearing the device (such as pain, discomfort, tenderness or skin irritation, or ear infections) · adults with tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Hearing aid vs sound generator CI: confidence interval · adults with tinnitus Sound therapy (using amplification devices and/or sound generators) for tinnitus (2018) · Cochrane | no estimate extracted | NR | No studies |
Bilateral vs unilateral hearing aids Hearing‐specific HRQL · adults with hearing loss Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults (2017) · Cochrane | no estimate extracted | NR | No studies |
Bilateral vs unilateral hearing aids Adverse effects: pain or discomfort in the ear, initiation or exacerbation of middle or outer ear infection · adults with hearing loss Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults (2017) · Cochrane | no estimate extracted | NR | No studies |
Bilateral vs unilateral hearing aids Generic HRQL ‐ not measured · adults with hearing loss Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults (2017) · Cochrane | no estimate extracted | NR | No studies |
Bilateral vs unilateral hearing aids Listening ability · adults with hearing loss Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults (2017) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse effects of treatment · adults over 18 years with tinnitus Zinc supplementation for tinnitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · adults over 18 years with tinnitus Zinc supplementation for tinnitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic impact associated with work · adults over 18 years with tinnitus Zinc supplementation for tinnitus (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Anxiety and depression disorders · adults over 18 years with tinnitus Zinc supplementation for tinnitus (2016) · Cochrane | no estimate extracted | NR | No studies |